Therapeutic Strategies for Reduction of the Cardiovascular Risk in Patients With Inflammatory Joint Diseases

Annual for Hospital Pharmacy
doi 10.14748/.v3i1.4066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical University Prof. Dr. Paraskev Stoyanov - Varna

Related search

Total Joint Arthroplasty in Patients With Inflammatory Rheumatic Diseases

Advances in Therapy
MedicinePharmacology
2018English

Inflammatory Joint Diseases

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Managing Cardiovascular Risk in Patients With Inflammatory Arthritis: Practical Considerations

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2016English

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Cardiovascular Risk in Patients With Inflamma-Tory Bowel Diseases: A Review

Romanian Biotechnological Letters
2019English

Reduction of Risk Factors for Cardiovascular Diseases in Morbid-Obese Patients Following Biliary-Intestinal Bypass: 3 Years' Follow-Up

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2004English

Effects of Long-Term Statin-Treatment on Coronary Atherosclerosis in Patients With Inflammatory Joint Diseases

PLoS ONE
Multidisciplinary
2019English

The Association Between Microalbuminuria and Peripheral Atherosclerosis in Patients With Risk Factors of Cardiovascular Diseases

Heart
Cardiovascular MedicineCardiology
2011English

MicroRNA: A New Therapeutic Strategy for Cardiovascular Diseases

Trends in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy